U.S. Water Utilities Stock News

NYSE:AMTB
NYSE:AMTBBanks

Amerant Bancorp Q4 Net Interest Margin Near 3.8% Tests Bullish Profitability Narrative

Amerant Bancorp (AMTB) closed out FY 2025 with Q4 total revenue of US$108.7 million and basic EPS of US$0.07, while trailing twelve month EPS stood at US$1.26 on revenue of US$394.2 million. The company has seen quarterly revenue range from US$86.98 million to US$108.7 million in 2025, with EPS moving from US$0.28 in Q1 to US$0.55 in Q2, US$0.35 in Q3 and US$0.07 in Q4, and trailing twelve month net income reaching US$52.4 million. For investors, the key point is how these earnings and margin...
NYSE:SN
NYSE:SNConsumer Durables

SharkNinja Adds New Accounting Leader As Shares Trade Below Targets

SharkNinja (NYSE:SN) has appointed Kaitlin Folan as Principal Accounting Officer and Chief Accounting Officer. Folan brings prior executive experience and extensive accounting expertise to the company’s finance leadership team. The change adds a new senior figure to SharkNinja’s financial oversight structure, which may interest current and prospective shareholders. For investors watching SharkNinja at a share price of $123.44, this leadership move sits alongside a mixed recent return...
NYSE:ABT
NYSE:ABTMedical Equipment

Abbott Laboratories (ABT) Margin Compression Challenges Steady Compounder Narrative After FY 2025 Results

Abbott Laboratories (ABT) has wrapped up FY 2025 with fourth quarter revenue of US$11.5b and basic EPS of US$1.02, alongside net income of US$1.8b, setting the stage for a year that investors will likely parse closely. The company has seen quarterly revenue move from US$10.6b in Q3 2024 to US$11.5b in Q4 2025, while basic EPS over that span has ranged from about US$0.95 to US$1.02. This compares with a trailing twelve month EPS of US$3.73 and a net profit margin that is compressed compared...
NasdaqGS:REAL
NasdaqGS:REALSpecialty Retail

A Look At RealReal (REAL) Valuation As Athena Targets Faster Luxury Resale Operations

How Athena could matter for RealReal stock The RealReal (REAL) recently rolled out its Athena system, a technology that helps validate luxury goods and shorten the time from item drop off to online listing. This development has put operational efficiency in sharper focus for investors. See our latest analysis for RealReal. Despite the Athena launch sharpening the focus on efficiency, RealReal’s recent share price performance has been mixed, with a 7 day share price return of 8.26% and a 90...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

A Look At Clover Health (CLOV) Valuation After Optimistic Analyst Views And 2026 Profitability Target

Why Clover Health is Back on Investors’ Radar Recent analyst commentary on Clover Health Investments (CLOV) has focused on three main areas: rapid Medicare Advantage membership growth, operational improvements, and management’s expectation of achieving GAAP profitability in 2026. See our latest analysis for Clover Health Investments. At a share price of US$2.59, Clover Health has seen a 7.47% year to date share price return and a 2.37% 1 month share price return, but a 32.20% 3 month share...